Clinical Trial Update: Feasibility Study of MID-C for AIS

View source ↗

Summary

A completed feasibility study evaluating MID-C for Adolescent Idiopathic Scoliosis (AIS), sponsored by Apifix.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adolescent Idiopathic Scoliosis

Drugs mentioned

• MID-C

Snippet

Sponsor: Apifix | Conditions: Adolescent Idiopathic Scoliosis (AIS) | Status: COMPLETED